318 related articles for article (PubMed ID: 8547630)
1. CD34: structure, biology, and clinical utility.
Krause DS; Fackler MJ; Civin CI; May WS
Blood; 1996 Jan; 87(1):1-13. PubMed ID: 8547630
[No Abstract] [Full Text] [Related]
2. [The function of the CD34 molecule: still an unknown].
Inglés Esteve J; Azqueta C; García López J
Sangre (Barc); 1996 Feb; 41(1):47-54. PubMed ID: 8779035
[No Abstract] [Full Text] [Related]
3. Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: a useful reage for identifying and characterizing blood vessels and hematopoietic precursors.
Garlanda C; Berthier R; Garin J; Stoppacciaro A; Ruco L; Vittet D; Gulino D; Matteucci C; Mantovani A; Vecchi A; Dejana E
Eur J Cell Biol; 1997 Aug; 73(4):368-77. PubMed ID: 9270880
[TBL] [Abstract][Full Text] [Related]
4. CD34-positive cells: biology and clinical relevance.
Stella CC; Cazzola M; De Fabritiis P; De Vincentiis A; Gianni AM; Lanza F; Lauria F; Lemoli RM; Tarella C; Zanon P
Haematologica; 1995; 80(4):367-87. PubMed ID: 7590508
[No Abstract] [Full Text] [Related]
5. Structural and functional features of the CD34 antigen: an update.
Lanza F; Healy L; Sutherland DR
J Biol Regul Homeost Agents; 2001; 15(1):1-13. PubMed ID: 11388737
[TBL] [Abstract][Full Text] [Related]
6. Quantification of CD34 epitopes in AML.
Sutherland R; Keeney M; Gratama JW
Haematologica; 2003 Jun; 88(6):ELT22; author reply ELT23. PubMed ID: 12801861
[No Abstract] [Full Text] [Related]
7. The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells.
Uchida N; Yang Z; Combs J; Pourquié O; Nguyen M; Ramanathan R; Fu J; Welply A; Chen S; Weddell G; Sharma AK; Leiby KR; Karagogeos D; Hill B; Humeau L; Stallcup WB; Hoffman R; Tsukamoto AS; Gearing DP; Péault B
Blood; 1997 Apr; 89(8):2706-16. PubMed ID: 9108388
[TBL] [Abstract][Full Text] [Related]
8. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
[TBL] [Abstract][Full Text] [Related]
9. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.
Smith FO; Rauch C; Williams DE; March CJ; Arthur D; Hilden J; Lampkin BC; Buckley JD; Buckley CV; Woods WG; Dinndorf PA; Sorensen P; Kersey J; Hammond D; Bernstein ID
Blood; 1996 Feb; 87(3):1123-33. PubMed ID: 8562938
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies reacting with myeloid cells.
Robak T; Goldman JM
Br J Haematol; 1985 Sep; 61(1):1-9. PubMed ID: 2413877
[No Abstract] [Full Text] [Related]
11. CD34 expression in de novo acute myeloid leukaemia.
Sperling C; Büchner T; Sauerland C; Fonatsch C; Thiel E; Ludwig WD
Br J Haematol; 1993 Nov; 85(3):635-7. PubMed ID: 7510996
[No Abstract] [Full Text] [Related]
12. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
13. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
[TBL] [Abstract][Full Text] [Related]
14. CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors.
Fennie C; Cheng J; Dowbenko D; Young P; Lasky LA
Blood; 1995 Dec; 86(12):4454-67. PubMed ID: 8541534
[TBL] [Abstract][Full Text] [Related]
15. The CD34 molecule and hematopoietic progenitor cell studies--a challenge in clinical medicine.
Egeland T
Vox Sang; 1998; 74 Suppl 2():467-8. PubMed ID: 9704483
[TBL] [Abstract][Full Text] [Related]
16. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML).
Green CL; Loken M; Buck D; Deeg HJ
Leukemia; 2000 Apr; 14(4):770-2. PubMed ID: 10764169
[No Abstract] [Full Text] [Related]
17. Expression of an L-selectin ligand on hematopoietic progenitor cells.
Sackstein R
Acta Haematol; 1997; 97(1-2):22-8. PubMed ID: 8980607
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
[TBL] [Abstract][Full Text] [Related]
19. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
20. Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts.
Lanza F; Moretti S; Castagnari B; Montanelli F; Latorraca A; Ferrari L; Bardi A; Dominici M; Campioni D; Dabusti M; Piva N; Lodi G; Reverberi R; Castoldi G
Haematologica; 1999 Nov; 84(11):969-77. PubMed ID: 10553156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
